Normalizing fibroblasts “pre activation” using appropriate pharmacological substances could improve the high susceptibility of NBCCS patients toward BCCs development and, presumably, of human cancers associated to unbalanced SHH/PATCHED pathway. This evidence concerns the gene SHH and cancer.